COVID-19: all 7,776 studies

Page 33 of 78. Open to participants first (483), then studies with results posted, then the rest; newest registration first within each.

• Physical Fitness in Young Healthy Adults After COVID-19 InfectionCompletedNCT05133622Not applicable
• COVID-19 VACCINE SAFETY AND EFFECTIVENESSStatus unknownNCT05133609Phase 1/2
• Allogenic UCMSCs as Adjuvant Therapy for Severe COVID-19 PatientsStatus unknownNCT05132972Phase 2/3
• Safety and Immunogenicity of HDT-301 Targeting a SARS-CoV-2 Variant Spike ProteinCompletedNCT05132907Phase 1
• The Immune Response of Heterologous Boost Third Dose of mRNA and Protein COVID-19 VaccineStatus unknownNCT05132855Phase 1/2
• Evaluating the Response of the Immune System of People With Long COVID (Post SARS-CoV-2)CompletedNCT05131594
• Infection Prevention and Control Practices Regarding COVID-19CompletedNCT05130749
• The Impact of COVID-19 Pandemic on Clinical Presentation and Staging of Gastric CancerCompletedNCT05130710
• Nutritional Supplementation of Flavonoids Quercetin and Curcumin for Early Mild Symptoms of COVID-19CompletedNCT05130671Not applicable
• Proning Early in Awake COVID-19 Hypoxic Respiratory Failure (PREACHR) StudyCompletedNCT05130541Not applicable
• Impact of Antiphospholipid Antibodies on Thrombin Generation During Sars-CoV2 Infection (TACIT2 Study)Status unknownNCT05128760
• Evaluation of Inactivated Vaccine in Healthy Adults Against Coronavirus Disease of 2019 (COVID-19)Status unknownNCT05128721Phase 1
• Immune Response of Asymptomatic EHPAD Employees Infected With COVID-19WithdrawnNCT05128656Not applicable
• Clinical Study on the Immune Program of Recombinant Novel Coronavirus（COVID-19) Vaccine (CHO Cell)Status unknownNCT05128643Phase 3
• Coronavirus Pediatric Serological StudyCompletedNCT05128435
• Analysis of Emergency Department Visits According to Incidence of Covid-19CompletedNCT05126641
• The South Proxa-Rescue AndroCoV Trial Against COVID-19CompletedNCT05126628Phase 3
• Vitamin D Supplementation and Clinical Improvement in COVID-19CompletedNCT05126602Not applicable
• The Immunogenicity, Safety, and Effectiveness of the COVID-19 Inactivated VaccineStatus unknownNCT05126550
• Effects of Cranial Electrotherapy Stimulation on Anxiety of Patients After COVID-19CompletedNCT05126511Not applicable
• Influence of the COVID-19 Pandemic on Dutch Surgical Patterns of CareCompletedNCT05126498
• Remote Assessment of Outpatient With Severe Acute Respiratory Syndrome (SARS-CoV-2)CompletedNCT05125887
• Clinical Study for Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01) Booster ImmunizationStatus unknownNCT05125874Not applicable
• Periodontal Maintenance and the COVID-19 PandemicCompletedNCT05125835
• Extracellular Vesicles Infusion Treatment for Mild-to-Moderate COVID-19WithdrawnNCT05125562Phase 2
• The Canadian COVID-19 Prospective Cohort StudyActive, not recruitingNCT05125510
• The Impact of Covid-19 on Patients Waiting for Knee SurgeryStatus unknownNCT05124613
• Prediction for Critical Outcomes of Patients With COVID-19Status unknownNCT05124587
• Transplacental Transmission of COVID-19TerminatedNCT05124574
• Study to Evaluate the inHaled Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector) On the Protective-Efficacy in Adults (SeiHOPE)WithdrawnNCT05124561Phase 3
• Sleep Characteristics in Post-COVID-19 PatientsCompletedNCT05124548
• Population-based Age-stratified Seroepidemiological Investigation Protocol for Coronavirus 2019 (COVID-19) Infection in the Federation of Bosnia and HerzegovinaStatus unknownNCT05124535
• Immune Response to Third Dose of COVID-19 Vaccine in Solid Organ TransplantCompletedNCT05124509
• Validation of HyperDetector for SARS-CoV-2SuspendedNCT05124496
• Anti-COVID19 VaccinaTion AKS-452 BOOSTER (ACT-BOOSTER Study)Status unknownNCT05124483Phase 2
• Analysis of Cardiac Damage Post Infection With SARS-CoV-2 and Post Vaccination Against COVID-19CompletedNCT05124223
• Extended Prone Position Duration COVID-19-related ARDS: a Retrospective StudyCompletedNCT05124197
• Immunogenicity and Reactogenicity Following a Booster Dose of COVID-19 mRNA Vaccine (Pfizer-BioNtech) and Two Adjuvanted Sub-unit Vaccines (SP/GSK) Administered in Adults Who Received 2 Doses of Pfizer-BioNTech mRNA Vaccine as a Primary VaccinationStatus unknownNCT05124171Phase 3
• COVID-19 Severity and Psychiatric MorbidityCompletedNCT05124158
• Primary Care in AURA for COVID-19CompletedNCT05124145
• Self-Perceived in Medical Students Undergoing Distance LearningCompletedNCT05123573
• PREVENT-COVID-19: A Q-Griffithsin Intranasal SprayCompletedNCT05122260Phase 1
• Mesenchymal Stem Cell Secretome In Severe Cases of COVID-19CompletedNCT05122234Phase 3
• Famotidine in Covid-19 Intensive Care UnitCompletedNCT05122208
• Controlled Trial of Angiotensin Receptor Blocker (ARB) & Chemokine Receptor Type 2 (CCR2) Antagonist for the Treatment of COVID-19TerminatedNCT05122182Phase 2
• Covid-19 Pandemic and Use of Video LaryngoscopyCompletedNCT05121701Not applicable
• Effectiveness of a Physical Therapy Telerehabilitation Program in Long Post COVID-19 Symptoms in Primary Health Care.CompletedNCT05121688Not applicable
• COVID-19 Vaccine Biomarker Study in Multiple SclerosisCompletedNCT05121662
• Patients' Attitudes Toward and Experiences With Buprenorphine TreatmentSuspendedNCT05121428
• Immune Response to Third Dose of SARS-CoV-2 Vaccine in a Cohort of Cancer Patients on Active TreatmentStatus unknownNCT05119738
• POC Study to Evaluate the Performance of the AcuVid COVID-19 Rapid Antigen Saliva TestStatus unknownNCT05119530
• COVID-19 Clinical Status Associated With Outcome Severity: An Unsupervised Machine Learning ApproachCompletedNCT05119465
• COVID-19 (Coronavirus Disease-2019) Psychiatric OutcomesTerminatedNCT05119400
• Intranasal INNA-051 for Prevention of COVID-19 in AdultsWithdrawnNCT05118763Phase 2
• Adding Colchicine to Tocilizumab in Patients With Severe COVID-19 Pneumonia.Status unknownNCT05118737Early Phase 1
• Sequelae of COVID-19 With Focus on Exercise Capacity and Underlying MechanismsStatus unknownNCT05118711
• Generic Behavioural Change Campaign for COVID-19 PreventionCompletedNCT05118373Not applicable
• ExoFlo™ Infusion for Post-Acute COVID-19 and Chronic Post-COVID-19 SyndromeWithdrawnNCT05116761Phase 1/2
• COVID19 Vaccine in SOT Adult RecipientsCompletedNCT05116748
• Obstructive Sleep Apnoea Post Covid 19: Role of the Upper Airway MicrobiomeStatus unknownNCT05116657
• The Effect of Neuro Linguistic Programming on COVID-19 Fear in Kidney TransplantCompletedNCT05115435Not applicable
• AI Evaluation of COVID-19 Sounds (AI-EChOS)Status unknownNCT05115097
• The Effect of the COVID-19 Epidemic Process on the Nutritional Habits and Body Weights of AdultsStatus unknownNCT05115084
• Online Childbirth Preparation Education in Covid-19 PandemicCompletedNCT05115071Not applicable
• Plasma SARS-CoV-2 RNA Levels in Critically Ill COVID-19 PatientsCompletedNCT05115045
• A Clinical Trial to Evaluate the Efficacy of RUTI® to Reduce the Severity of SARS-CoV-2 Infection (COVID-19)WithdrawnNCT05115019Phase 2/3
• Preoperative Anxiety During COVID-19CompletedNCT05114967
• Health System Dynamic & Resource Requirement in a South African COVID-19 Field HospitalCompletedNCT05113875
• A Phase-I Study of a Nanoparticle-based Peptide Vaccine Against SARS-CoV-2CompletedNCT05113862Phase 1
• Study to Evaluate the Safety and Immunogenicity of SARS-CoV-2 Vaccine (IN-B009) in Healthy Adults (COVID-19)Status unknownNCT05113849Phase 1
• LIPId Profile Changes in Inflammatory Conditions Induced by SARS-CORoronavirus-2CompletedNCT05113836
• In Situ Simulation Training in Transferring Critically Ill COVID-19 PatientsCompletedNCT05113823Not applicable
• The Potential Use of Nebulized Hydroxychloroquine for the Treatment of COVID-19Status unknownNCT05113810Phase 2
• the Safety and Efficacy of Meplazumab in Patients With COVID-19CompletedNCT05113784Phase 2/3
• Adverse Reactions Following COVID-19 Vaccination Among Ecuadorian Healthcare WorkersCompletedNCT05113472
• Lot-to-lot Consistency of an Inactivated SARS-CoV-2 Vaccine Between Different Workshops in Healthy Children Aged 3-17 YearsActive, not recruitingNCT05112913Phase 4
• Osteopathic Manipulative Therapy Effects on Prolonged Post-COVID Olfactory DysfunctionCompletedNCT05112887Not applicable
• ImmuneSense™ COVID-19 Cross-Reactivity StudyWithdrawnNCT05112874
• A Study to Evaluate Safety and Immunogenicity of a COVID-19 Vaccine in People Living With HIV at Risk for SARS-CoV-2 (COVID-19)CompletedNCT05112848Phase 2
• Does Repeat Influenza Vaccination Constrain Influenza Immune Responses and ProtectionActive, not recruitingNCT05110911
• QUALITATIVE SURVEY ABOUT NURSES FIRST WORK EXPERIENCE DURING COVID-19 PANDEMICStatus unknownNCT05110859
• The Danish Pre-HCQ COVID Dialysis StudyWithdrawnNCT05110651Phase 4
• Effects of the Programme Developed for Sedentary Elderly in the COVID-19 Pandemic: Mobile Interventional StudyCompletedNCT05110560Not applicable
• Clinical Trial of Immunogenicity Bridging of a Recombinant New Coronavirus（COVID-19） Vaccine (CHO Cell)CompletedNCT05109598Phase 2
• Determinants of the Level of Anti-SARS-CoV-2 IgG ANTibodiEs After Vaccination StudyStatus unknownNCT05109585
• The Impact of the Covid-19 Pandemic on Schizophrenia Patients Registered With the Community Mental Health CenterCompletedNCT05109572
• Ad26.COV2.S as a Heterologous Booster in Adults After Single- or Two-Dose of Inactivated COVID-19 VaccineStatus unknownNCT05109559Phase 1/2
• Geriatric COVID-19 SerologyStatus unknownNCT05109546
• Immunogenicity And Safety of COVID-19 Vaccine , Inactivated Co -Administration With EV71 Vaccine (Vero Cell)CompletedNCT05107557Phase 4
• Effectiveness of Interactive Voice Response for COVID-19 Vaccination Training in the Democratic Republic of the CongoCompletedNCT05107479Not applicable
• BREATHE: Virtual Self-management for Long COVID-19CompletedNCT05107440Not applicable
• Clinical Study of Recombinant Novel Coronavirus（COVID-19） Vaccine (CHO Cell) Combined With Influenza VaccineCompletedNCT05107375Phase 3
• Evaluation of Long Haul COVID-19 and Vaccine Immunogenicity in Patients With Liver DiseaseCompletedNCT05107271
• A Clinical Evaluation of Pine Trees Health Test System Including the Pine Trees Health Reader and COVID-19 Test for Point-of-CareCompletedNCT05107258
• Observational Study on the Diagnostic Evaluation of the Intestinal Microbiota of Patients With COVID-19.CompletedNCT05107245
• A Randomized Study to Determine the Expression of the Furin Protein in Patients With SARS-CoV-2 and Vaccinated Against CoronavirusTerminatedNCT05104840
• Integrative Medicine Impact on Frontline COVID-19 Personnel WellbeingCompletedNCT05104827Not applicable
• Evaluation of Immunogenicity, Safety and Antibody Persistence of COVID-19 Booster Vaccine (Produced in Wuhan) in Patients With Hypertension and/or DiabetesStatus unknownNCT05104437Phase 4
• Rehabilitation in Severely Ill Inpatients With COVID-19CompletedNCT05104411
• Hemoperfusion With the Efferon CT Extracorporeal Adsorbers in Patients With Severe Covid-19CompletedNCT05104398

← COVID-19 overview